Richards, Paul

Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer

O'Shaughnessy, J., Schwartzberg, L., Danso, M. A., Miller, K. D., Rugo, H. S., Neubauer, M., Robert, N., Hellerstedt, B., Saleh, M., Richards, P., et al. (2014) · Journal of Clinical Oncology

Breast Cancer Treatment StudiesPARP inhibition in cancer therapy

Cited by 311

Final analysis of phase II study of EZN-2208 (PEG-SN38) in metastatic breast cancer (MBC).

Osborne, C. R. C., O'Shaughnessy, J., Holmes, F. A., Kim, H. S., Kocs, D. M., Steinberg, M. S., Richards, P. D., Vukelja, S. J., Berkowitz, N. C., & Buchbinder, A. (2012) · Journal of Clinical Oncology

Cancer Treatment and PharmacologyCancer therapeutics and mechanisms

Cited by 10